Please login to the form below

Not currently logged in
Email:
Password:

Purdue Pharma

This page shows the latest Purdue Pharma news and features for those working in and with pharma, biotech and healthcare.

J&J proposes $4bn in cash to settle opioid crisis allegations

J&J proposes $4bn in cash to settle opioid crisis allegations

Also in the firing line was Purdue Pharma, which filed for bankruptcy following increasing blame for its role in fuelling the epidemic. ... Under this agreement, Purdue is set to provide over $10bn in helping to address the epidemic – some states

Latest news

  • Johnson & Johnson agrees $20.4m settlement in Ohio over opioid crisis Johnson & Johnson agrees $20.4m settlement in Ohio over opioid crisis

    It also settled with two other opioid drugmakers, including a $270m deal with Purdue Pharma and an $85m deal with Teva Pharmaceuticals. ... Purdue Pharma, privately-owned by the Sackler family and the manufacturer of the now infamous opioid product

  • Insys gets bankruptcy court okay for Subsys sale Insys gets bankruptcy court okay for Subsys sale

    Since then, Purdue Pharma has also filed for Chapter 11 protection as it tries to secure agreement for a massive $10bn-$12bn settlement relating to its alleged role in the opioid ... Wyoming-based BTcP Pharma, which is part of the MMB Healthcare network

  • Purdue Pharma files for bankruptcy after opioid settlement Purdue Pharma files for bankruptcy after opioid settlement

    Company has faced brunt of blame for fuelling epidemic. Purdue Pharma has filed for bankruptcy, following increasing blame for its role in fuelling the opioid epidemic in the US. . ... to cope with the opioid crisis,” said Steve Miller, chairman of

  • Mallinckrodt offloads CDMO for $250m Mallinckrodt offloads CDMO for $250m

    This will likely include the active ingredient for Acthar, which the pharma company has faced criticism for due to its inflated pricing. ... Both Teva Pharmaceuticals and Purdue Pharma paid $85m and $270m respectively in out of court settlements.

  • J&J found liable in first opioid mis-marketing verdict J&J found liable in first opioid mis-marketing verdict

    Oklahoma had also sued Teva Pharmaceuticals and Purdue Pharma, but both these companies agreed to settle out of court (for $85m and $270m respectively). ... Purdue, the privately held maker of opioid drug OxyContin, has taken the brunt of the blame for

More from news
Approximately 4 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    825. Exicure (US). Purdue Pharma (US). Research collaboration &options. Spherical Nucleic Acid (SNA) technology for discovery and development of psoriasis treatment; option to AST-005. ... and Bicycle Therapeutics at $1bn, and the Purdue Pharma-Exicure

  • Pharma deals in September 2015 Pharma deals in September 2015

    Let's deal with the pain first …. After last month's deal with Eisai for lemborexant, a phase III insomnia treatment, Purdue Pharma is refocusing on its pain portfolio by ... Collaboration - public private partnership. 220. VM Pharma. Purdue Pharma.

  • Pharma deals during December 2012 Pharma deals during December 2012

    phase II for treatment of pain. Xenon has been very successful in closing deals with Big Pharma companies including Merck, Novartis and Genentech. ... What perhaps is a mystery is why Titan made this deal with a newly formed marketing company rather

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Purdue Pharma appoints Dr Craig Landau as its CEO Purdue Pharma appoints Dr Craig Landau as its CEO

    He also takes up president role. Purdue Pharma has appointed Dr Craig Landau as its new chief executive officer and president, roles that will see him be responsible for the ... He succeeds Mark Timey who leaves Purdue Pharma to “pursue other career

  • McCann Health expands consulting team McCann Health expands consulting team

    various sales and marketing positions at Johnson &Johnson, Purdue Pharma and Bristol-Myers Squibb.

  • Purdue Pharma appoints Dr Alan Dunton Purdue Pharma appoints Dr Alan Dunton

    Purdue Pharma has appointed Dr Alan Dunton as senior vice president of research and development in a role that also sees him join its executive committee. ... In 2006, he. founded Danerius, a biotechnology and pharmaceutical consulting business, which he

  • Purdue looks to Merck for new CEO Purdue looks to Merck for new CEO

    Mark Timney will lead pain specialist. Purdue Pharma has appointed Merck &Co veteran Mark Timney as CEO, replacing John Stewart who retires. ... Dr Raymond Sackler, co-founder and board member of pain specialist Purdue, said they had found a “proven

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics